Brief: TELA Bio Q1 Revenue USD 18.52 Million Vs. IBES Estimate USD 17.4 Million
May 08 (Reuters) - TELA Bio Q1 basic EPS USD -0.25. Q1 income from operations USD -10.472 million Q1 gross profit USD 12.512 million Q1 net income USD -11.264 million Q1 operating expenses USD 22.984 million outlook FY revenue USD 85-88 million
Recent news on TELA Bio
See all newsBrief: Tela Bio - Receives FDA 510(K) Clearance For Liora Monofilament Scaffold For Soft Tissue Reinforcement
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview